Gene · 51441
Papers3,768
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,768
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| METTL3 obstructs vascular smooth muscle cells osteogenic reprogramming by methylating Runx2 in chronic kidney disease. | Commun Biol | 2025 | 40200050 | PubTator, text mining | PubMed |
| Mechanism of FBXW7 mRNA degradation mediated by circSMAD2 through METTL3-METTL14 m6A axis affects proliferation and invasion of endometrial stromal cells. | J Reprod Immunol | 2025 | 40184726 | PubTator, text mining | PubMed |
| H3K27-me3 Inhibition Induces YTHDF2-Mediated Decay of m6A-Marked Severe Acute Respiratory Syndrome Coronavirus 2 Transcripts. | J Med Virol | 2025 | 40183255 | PubTator, text mining | PubMed |
| The impact of YTHDF2-mediated NCOA4 methylation on myocardial ferroptosis. | Apoptosis | 2025 | 40167954 | PubTator, text mining | PubMed |
| YTHDF2 promotes the metastasis of oral squamous cell carcinoma through the JAK-STAT pathway. | Sci Rep | 2025 | 40119074 | PubTator, text mining | PubMed |
| Coupling mechanisms coordinating mRNA translation with stages of the mRNA lifecycle. | RNA Biol | 2025 | 40116043 | PubTator, text mining | PubMed |
| MEOX1-mediated transcriptional regulation of circABHD3 exacerbates hepatic fibrosis through promoting m6A/YTHDF2-dependent YPEL3 mRNA decay to activate β-catenin signaling. | PLoS Genet | 2025 | 40100806 | PubTator, text mining | PubMed |
| The role of YTHDF2 in anti-tumor immunity. | Cell Investig | 2025 | 40092843 | PubTator, text mining | PubMed |
| METTL3 suppressing SLC31A1 m6A modification regulates trophoblast migration and invasion. | Placenta | 2025 | 40088504 | PubTator, text mining | PubMed |
| TRIM8 enhances chondrocyte ferroptosis by inhibiting YTHDF2-m6A mediated SREBF2 mRNA degradation to promote OA progression. | Int Immunopharmacol | 2025 | 40073810 | PubTator, text mining | PubMed |
| MAP4K4 aggravates microvascular anomalies in diabetic retinopathy in a YTHDF2-dependent manner. | Diabetologia | 2025 | 40072537 | PubTator, text mining | PubMed |
| Bacteroides fragilis Toxin Suppresses METTL3-Mediated m6A Modification in Macrophage to Promote Inflammatory Bowel Disease. | J Crohns Colitis | 2025 | 40065724 | PubTator, text mining | PubMed |
| N‑methyladenosine reader YTHDF2‑mediated AC026691.1 degradation promotes gastric cancer cell proliferation, migration and M2 macrophage polarization. | Mol Med Rep | 2025 | 40052573 | PubTator, text mining | PubMed |
| Exon junction complexes regulate osteoclast-induced bone resorption by influencing the NFATc1 m6A distribution through the "shield effect". | Clin Transl Med | 2025 | 40051055 | PubTator, text mining | PubMed |
| Natural product mediated mesenchymal-epithelial remodeling by covalently binding ENO1 to degrade m6A modified β-catenin mRNA. | Acta Pharm Sin B | 2025 | 40041899 | PubTator, text mining | PubMed |
| ALKBH3-Mediated M1A Demethylation of METTL3 Endows Pathological Fibrosis:Interplay Between M1A and M6A RNA Methylation. | Adv Sci (Weinh) | 2025 | 40019372 | PubTator, text mining | PubMed |
| Phenylpyrazoles as Inhibitors of the m6A RNA-Binding Protein YTHDF2. | JACS Au | 2025 | 40017738 | PubTator, text mining | PubMed |
| Comprehensive Analysis Reveals Midnolin as a Potential Prognostic, Therapeutic, and Immunological Cancer Biomarker. | Biomedicines | 2025 | 40002690 | PubTator, text mining | PubMed |
| Biological functions of 5-methylcytosine RNA-binding proteins and their potential mechanisms in human cancers. | Front Oncol | 2025 | 39990690 | PubTator, text mining | PubMed |
| USP14 modulates stem-like properties, tumorigenicity, and radiotherapy resistance in glioblastoma stem cells through stabilization of MST4-phosphorylated ALKBH5. | Theranostics | 2025 | 39990235 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51441/papers?page=17